2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$5.12+$0.03 (+0.57%)
Price as of Jul 14, 2026 8:39 AM EDT- $139.4MMarket Cap
- 4.30%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$5.12+$0.03 (+0.57%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.09 | ||
Change | -$0.12 (-2.30%) | ||
Open | $5.19 | ||
High | $5.19 | ||
Low | $4.93 | ||
Previous Close | $5.21 | ||
Volume | 1,175,869 | ||
30-Day Average Volume | 3,157,706 | ||
1-Week Change | -5.04% | ||
1-Month Change | -29.79% | ||
1-Year Change | 4.30% | ||
3-Year Change | -58.95% | ||
5-Year Change | -91.30% | ||
Fundamentals | |||
Shares Outstanding | 27.4M | ||
Total Assets | $64.4M | ||
Market Cap | $139.4M | ||
Enterprise Value | $102.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$12.8M | ||
EBITDA | -$12.8M | ||
Net Working Capital | $37.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue